Wilms' tumor: prognostic factors for patients without metastases at diagnosis: results of the National Wilms' Tumor Study
- PMID: 205340
- DOI: 10.1002/1097-0142(197804)41:4<1577::aid-cncr2820410448>3.0.co;2-7
Wilms' tumor: prognostic factors for patients without metastases at diagnosis: results of the National Wilms' Tumor Study
Abstract
Multivariate statistical analyses are used to evaluate a wide range of factors in predicting relapse and survival for 429 children enrolled in the National Wilms' Tumor Study. Anaplastic or sarcomatous histology, specimen weight over 250 grams, positive regional lymph nodes, treatment with only a single drug and age over two years are the most important predictors of relapse. The first three factors also predict mortality. Laterality, capsular penetration, intrarenal vascular invasion, direct regional extension and operative spillage have lesser effects which do not contribute significantly to the multivariate prediction equations, while sex, race and the presence of a tumor thrombus in the renal vein have essentially no effect. Treatment with combination chemotherapy is confirmed to be efficacious regardless of what prognostic factors are operating. A statistical model allows prediction of relapse and death for each of 24 patient subgroups, with the estimates of percentage relapsed ranging from 3% to 100%.
Similar articles
-
Prognosis for Wilms' tumor patients with nonmetastatic disease at diagnosis--results of the second National Wilms' Tumor Study.J Clin Oncol. 1985 Apr;3(4):521-31. doi: 10.1200/JCO.1985.3.4.521. J Clin Oncol. 1985. PMID: 2984345
-
Anaplastic Wilms' tumor: clinical and pathologic studies.J Clin Oncol. 1985 Apr;3(4):513-20. doi: 10.1200/JCO.1985.3.4.513. J Clin Oncol. 1985. PMID: 2984344
-
Relapse-associated variables in stage I favorable histology Wilms' tumor. A report of the National Wilms' Tumor Study.Cancer. 1987 Sep 15;60(6):1204-12. doi: 10.1002/1097-0142(19870915)60:6<1204::aid-cncr2820600608>3.0.co;2-w. Cancer. 1987. PMID: 3040208
-
Current therapy for Wilms' tumor.Oncologist. 2005 Nov-Dec;10(10):815-26. doi: 10.1634/theoncologist.10-10-815. Oncologist. 2005. PMID: 16314292 Review.
-
Clinical features, treatment, and outcomes of bilateral Wilms' tumor: A systematic review and meta-analysis.J Pediatr Surg. 2018 Dec;53(12):2465-2469. doi: 10.1016/j.jpedsurg.2018.08.022. Epub 2018 Sep 1. J Pediatr Surg. 2018. PMID: 30274708
Cited by
-
Current and emerging chemotherapy treatment strategies for Wilms tumor in North America.Paediatr Drugs. 2008;10(2):115-24. doi: 10.2165/00148581-200810020-00006. Paediatr Drugs. 2008. PMID: 18345721 Review.
-
Current impact of adjuvant chemotherapy in resectable cancer.Cancer Chemother Pharmacol. 1979;3(1):7-16. doi: 10.1007/BF00254414. Cancer Chemother Pharmacol. 1979. PMID: 231489 Review. No abstract available.
-
Characteristics and Outcome of Children with Wilms Tumor Requiring Intensive Care Admission in First Line Therapy.Cancers (Basel). 2022 Feb 14;14(4):943. doi: 10.3390/cancers14040943. Cancers (Basel). 2022. PMID: 35205701 Free PMC article.
-
Management of Wilms' tumor and neuroblastoma.Indian J Pediatr. 1981 Jul-Aug;48(393):509-17. doi: 10.1007/BF02822300. Indian J Pediatr. 1981. PMID: 6276297 No abstract available.
-
Adult Wilms' tumor: report of a case and review of the literature.Jpn J Surg. 1990 Sep;20(5):585-9. doi: 10.1007/BF02471017. Jpn J Surg. 1990. PMID: 2173800 Review.